We further demonstrated that this mechanism underlies hepatic fibrosis in animal models, as well as in patients, by detecting the N-terminal side LAP degradation products (...QILSKLR58) ending at R58 residue (R58 LAP-DPs) in fibrotic livers using a specific antibody we generated [9]. Here, TGFB1 is linked to Hepatic fibrosis.